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Aging population and decreased physical activity due to increased life standards are two prevalent 
and inevitable factors that cause decrease in bone mineral mass, bone quantity, and muscle strength 
in the population. These consequences increase the incidence of bone fracture throughout the life 
of individuals. Although the bone has a great regenerative capacity compared to most other tissues 
or organs in the body, a proper healing of the bone requires appropriate alignment and fixation of 
fractured fragments throughout the process. There are different techniques and tools to provide bone 
substitutes with those properties. Most of the available fixation tools are made from non-eroding 
metals due to their inherent stiffness and toughness, the properties necessitated by the load bearing 
function of the skeletal system. Ideally, however, an implant should be temporary and be eliminated 
from the body as soon as its function is no longer necessary due to potential risks like late stage 
infection, bone resorption or immune reactions. For bone implants, due to the need for stabilization of 
fixation devices to the surrounding bone using screws or nails, removal operations may cause severe 
morbidity to the newly repaired fracture site. Another equally important problem with use of metal 
fixation devices is their superior mechanical properties that outweigh those of bone, lead the newly 
forming bone tissue not to be subjected to mechanical stimulation, which is a necessary requirement 
for bone forming machinery. Considering these problems, different biodegradable or bioerodible 
materials were suggested to be used in the production of temporary bone fracture fixation devices. 
This paper reviews the developments and trends in the field of biodegradable hard tissue implants, 
available materials, and their suitability to the host bone tissue.
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metals, biomechanics, biocompatibility.
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1. Introduction
Bone is a dynamic tissue in that bone 
formation and resorption occurs repeatedly by the 
action of osteoblasts and oteoclasts, respectively. 
The balance between these two processes is 
maintained by the current state of the body and 
physical activity. This is also valid in healing 
and remodeling of a fracture site but with more 
parameters, including mechanical stimulus and 
condition and location of the fracture site. At 
this point, the mechanical properties are critical 
because too rigid fixation causes problems at 
– 4 –
Erkin Aydin and Vasif Hasirci. Biodegradable Hard Tissue Implants
the later stages of healing process. If there is 
not enough load transfer to the newly forming 
tissue, which is called stress shielding, new bone 
formation stops while bone resorption continues 
and this causes an osteoporotic and mechanically 
weak bone (Paavolainen et al., 1978). Therefore, 
the early advantages of standard metallic fixation 
devices turn out to be problem in later stages 
of the bone healing process. In this context, 
biodegradable implants would be better suited 
to the loading requirements of the bone. By 
controlling the degradation rate and thus the loss 
of intrinsic stiffness, implants can be tailor-made 
to satisfy the load transfer requirements of the 
newly forming bone. 
1.1. Bone Healing
Bone healing is a complicated yet controlled 
process, and is a more regenerative process 
than simple repair. Bone fracture results in an 
immediate hemorrhage and clot formation at the 
fracture site due to disruption of blood vessels 
at and nearby sites. Healing process starts with 
removal of the clot and the tissue and cell debris. 
Then fibroblasts residing in the inner layer of 
the periostum migrate and proliferate towards 
the injured site, to lay down a fibrous collagen 
matrix, called callus. It forms at both ends of the 
fractured bone segments and bridge the ends. 
Cartilage then forms at the site of the callus 
where there is not enough blood supply, followed 
by calcification by the action of osteoblasts. 
During this phase, cartilage is transformed first 
into trabecular bone and then to compact bone. 
In this period, new vascularization takes places, 
however, if the fracture site is not properly fixed, 
the newly formed vessels could be destroyed, 
retarding the healing process, and resulting in 
formation of a fibrous callus. Therefore, it is 
very important to stabilize the fracture site to 
achieve early vascularization. For this, use of the 
current gold standard metallic fixation devices 
is very appropriate. Their inherent strength 
and stiffness easily supports the initial high 
mechanical strength requirement. However, 
biodegradable fracture fixation implants, mostly 
of polymeric origin, cannot meet this criterion 
due to the intrinsic low mechanical properties of 
the polymers. Thus, polymeric implants cannot 
be produced in compact geometries unlike their 
metal counterparts, and fixation is problematic 
especially at the sites of restricted access or with 
small surfaces. This inappropriately low initial 
strength is the reason, why such biodegradable 
polymeric implants cannot be applied in fixation 
of fractures of weight bearing bones and need to 
be improved. 
1.2. Bone Augmentation Devices
Orthopedic implants, such as hip, spine, 
shoulder, and knee prostheses are mostly used 
in cases of loss of bone function as a result of 
degenerative joint diseases. These implants are 
meant to substitute the mechanical function 
of the tissues they replace and, therefore, their 
service life must be long, requiring them not to be 
manufactured from biodegradable materials. There 
are also those temporary implants which augment 
healing of fractured bones by helping to carry the 
body’s weight which cannot be borne due to the 
discontinuity caused by the fracture. Fracture 
fixation implants, e.g., plates, intramedullary 
nails, pins and screws, are included in this 
category. They are also used to stabilize the bone 
fragments in the correct shape during the healing 
period. In order not to interfere with the normal 
state and functioning of the surrounding tissues 
continuously and for patient comfort, it is the 
best that they are eliminated from the body soon 
after tissue healing is completed. This is because 
degradable foreign materials within the body, like 
metals or polymers, always have the potential to 
cause problems due to their degradation products 
including metal particles from corrosion, 
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inflammation, delayed infection (Bayston et al., 
2007), and accumulation of material debris at 
injury site resulting in tissue damage (Kim et al., 
1997; Mine et al., 2010). Therefore, if the implant 
cannot be biologically eliminated, this is done 
with surgery, which means another trauma for 
the injury site that increases the associated risk of 
infection, causes further cost, loss of work days 
and patient discomfort (pain). In fact, in order to 
avoid these problems, sometimes surgeons allow 
implants to remain in the body for the lifetime of 
the patient if a permanent implant is not foreseen 
to constitute a major problem. 
For the time being, bone, cartilage, and joint 
augmentation or replacement, and fixation of 
fractures of the load-bearing bones are achieved 
using metals (e.g. stainless steel, titanium) and 
metal alloys (e.g., nickel/titanium, zirconium, 
cobalt/chromium) (Niinomi, 2008; Fleck and 
Eifler, 2009; D’Antonio and Sutton, 2009;), 
polymers (e.g., polyetheretherketone) (Moon et 
al., 2009), or ceramics (e.g., aluminum oxide, 
glass-ceramics) (Thomas et al., 2005; D’Antonio 
and Sutton, 2009). All of these materials are 
essentially non degradable and they are chosen 
primarily due to their abilities to withstand the 
stress – strain levels, to which the bone is exposed 
during normal physical activities. For the fixation 
of fractures for some low or non-load bearing 
bones, there are some biodegradable implants 
including plates, rods, pins, and screws already 
on the market.
2. Bone Tissue Engineering
To overcome the inherent problems of 
autografting and allografting, tissue engineering 
has emerged as a significant research area in 
the context of regeneration of bone as well as 
other tissue and organs. Basically, it consists of 
obtaining tissue specific cells from a patient’s 
own body, growing them (in culture) on three-
dimensional scaffolds that mimic the tissue in 
question, and placing them into the defect site 
(Shin et al., 2003). The properties of the scaffold 
are important: it must possess high porosity and 
a high degree of interconnectivity between the 
pores so that cells can enter, colonize the depths 
of the material, and interact with each other. 
Similarly, tissue fluids carrying nutrients, and 
local and systemic factors can enter and leave the 
construct to guide and support cellular growth. 
The scaffold must also be bioabsorbable such 
that it is eliminated gradually as the tissue heals, 
while retaining appropriate level of mechanical 
properties in order to be able to serve its function 
until the tissue heals. 
Bone tissue engineering is specifically 
attractive in complex bone fractures, where there 
is loss of bone material and the gap between the 
fragments cannot be filled by the body itself. 
The limit beyond which the bone cannot heal by 
itself is called critical size bone defects, and in 
order to heal these defects some filling material, 
preferably osteoconductive and/or osteoinductive, 
is required. For optimal remodeling of the newly 
formed tissue, the implant needs to be replaced 
by the healing bone, thus necessitating the use 
of biodegradable materials. There are different 
approaches to filling such gaps; some use only 
porous implants, so that osteoblasts of the 
body migrate in, proliferate and deposit their 
extracellular material on the way to healing 
(Hutchens et al., 2009) while some others use the 
tissue engineering approach where the patient’s 
own mesenchymal stem cells are seeded in the 
porous filler constructs which might be allowed, 
ex vivo, to differentiate into osteoblasts within 
the constructs, and form new bone tissue after 
implantation, accelerating and facilitating bone 
healing. To those tissue engineering constructs, 
controlled delivery systems of bone morphogenic 
proteins (BMP) may be added to activate the bone 
cells to form bone and/or enhance remodeling 
(Basmanav et al., 2008; Yilgor et al., 2009), 
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likely by inducing blood vessel formation. Tissue 
engineering approach has to use biodegradable 
materials, mostly polymers and their composites 
with different ceramics (calcium phosphates), 
but because of the high porosity requirement for 
cell penetration, those scaffolds do not possess 
the mechanical strength needed to serve as an 
ultimate solution for bone fracture fixation. 
Therefore, tissue engineering approach is not the 
main concern of this article.
In order to allow fluid drain and cell entrance, 
and achieve attachment and proliferation for 
later tissue remodeling, tissue engineering 
scaffolds must have an inherent high porosity 
and interconnected pores (Karageorgiou and 
Kaplan, 2005). Though, high porosity adversely 
affects the mechanical properties of materials 
and is especially important for the bone tissue 
which is under continuous loading. Mechanical 
stimulus is an inevitable necessity for proper bone 
regeneration and any tissue engineering construct 
will be under the effect of it until it is absorbed. 
Designing highly porous, mechanically suitable 
scaffolds is particularly important when the implant 
has to be biodegradable. Therefore, generally 
the mechanical properties of the biodegradable 
scaffolds are compromised. To satisfy these 
requirements, a biodegradable composite ceramic 
scaffold composed of β-tricalcium phosphate (β 
-TCP) matrix and calcined hydroxyapatite (HA) 
nanofibers was prepared for load bearing bone 
applications (Ramay and Zhang, 2004). A high 
porosity (ca. 73 %) composite was obtained with 
a maximum compressive strength of ca. 10 MPa 
when 5 %, w/w HA nanofibers were used. This 
made the scaffold comparable to cancellous bone, 
since such material can only be implanted along 
with other supportive elements like a bone plate 
or intramedullary rod. 
An in vivo study (rat femoral segmental 
defect model) demonstrated the applicability of 
a biodegradable polymer/ceramic composite, 
poly(propylene fumarate) (PPF) and tricalcium 
phosphate (TCP), to serve as a temporary bone 
support while rhBMP-2 release was achieved 
from a porous dicalcium phosphate dehydrate 
carrier system (Chu et al., 2007). The implant 
was constructed of a hollow tube made from 
non-porous polymer/ceramic composite, to 
be placed in the intramedullary cavity of the 
defected femur, where a porous BMP-2 carrier 
is integrated into a hole drilled in this implant. 
The initial compressive strength was 23 MPa, 
decreased to 12 MPa after 12 weeks in phosphate 
buffered solution at 37 °C. Although the authors 
state that there is no need for bone plate or other 
means of stabilation due to sufficient inherent 
strength of the implant, they placed a (non-
degradable) stainless steel K wire through the 
internal cavity of the hollow tube-shaped implant 
in order to share the load. Therefore, even a non-
porous biodegradable implant might not have 
sufficient mechanical strength for bone fixation 
applications.
3. Biodegradable Polymeric  
Hard Tissue Implants 
Fixation of osteotomized and fractured bone 
segments is achieved using internal rigid fixation 
devices including plates and screws, and the gold 
standard material for these is titanium (Hasirci et 
al., 2000; Cheung et al., 2004) due to its inherent 
stiffness and biocompatibility. However, this ever-
lasting stiffness may cause the stress-shielding 
phenomenon mentioned earlier, resulting in 
osteoporotic bone and skeletal growth retardation 
in pediatric patients (Yaremchuk and Posnick, 
1995). Therefore, in order to overcome the 
problems associated with metal fixation devices, 
a number of polymer-based biodegradable plates 
and screws were devised and a number of them 
are already available and have some clinical 
experience. A detailed mechanical evaluation of 
7 currently available biodegradable osteofixation 
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systems and comparison of them with 2 titanium 
counterparts were reviewed by Buijs et al. 
(2007).
3.1. Polylactide/Glycolide Family 
As Biodegradable Hard Tissue Implants
Despite the presence of a large number 
of synthetic or natural origin biodegradable 
polymers studied in the context of biomaterials 
research (e.g. polylactide (PLA), polyglycolide 
(PGA), poly(lactide-co-glycolide) (PLGA), poly(ε-
caprolactone) (PCL), polyhydroxybutyrate (PHB), 
poly(hydroxybutyrate-co-hydroxyvalerate) 
(PHBV), chitosan, poly(2-hydroxyethyl 
methacrylate) (PHEMA), collagen, and hyaluronic 
acid), only a few of them are suitable as implant 
materials to be used in hard tissue regeneration due 
to stringent mechanical property requirements.
Historically, the most extensively studied 
biodegradable polymer as a biomaterial is lactide/
glycolide family of polymers and these efforts 
have resulted in the approval of their use within 
the body by FDA. Different formulations of PGA, 
PLA and PLGA have been studied extensively for 
this context. PGA is the simplest linear aliphatic 
member of the family and was used to produce 
the first completely absorbable synthetic suture in 
the 1960’s. The monomer glycolide is synthesized 
by dimerization of glycolic acid and then PGA is 
formed via ring opening polymerization (Fig. 1). 
It is a highly crystalline polymer (45-55 %), and 
therefore, it is not soluble in most organic solvents. 
PGA fibers have high tensile strength (70 – 138 
MPa) and modulus (6.9 GPa), and their high 
stiffness prevents easy processing and interferes 
with the properties of resulting product (Perrin 
and English, 1997). Therefore, only a small 
number of products were prepared using PGA. 
Their copolymers with lower stiffness values are 
more suitable for orthopedic applications, and, 
therefore, are used instead of PGA.
PLA is obtained through ring opening 
polymerization of lactide (Fig. 1); there are two 
lactide isomers, namely D and L forms. The 
stereopolymer PLLA is semicrystalline, with a 
crystallinity of around 37 %, and has the highest 
Fig. 1. Synthesis of PGA and PLA via ring opening polymerization
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inherent tensile strength and modulus (2.7 
GPa) among polylactides. Instead, PDLA is an 
amorphous polymer with lower tensile strength 
and modulus (2.0 GPa). On the other hand, PLLA 
needs a much longer time for degradation in the 
body than PDLA does. 
3.2. Degradation of Lactide  
and Glycolide Polymers
In vitro and in vivo degradation of PLGA 
polymers have been studied by numerous 
researchers during the last three decades. 
Simple chemical hydrolysis of the backbone is 
the predominant mechanism of degradation of 
these polymers. Semicrystalline polymers have 
repeating units that go into tight associations with 
each other, producing dense regions throughout the 
polymer backbone, called crystallites. Although 
this occurs due to steric effects, i.e. tacticity, 
these crystalline regions are tightly held together 
so that they act like chemical crosslinks and lead 
to increase in tensile strength and stiffness.
In semicrystalline polymers, water 
penetrates the bulk of the polymer material and 
attacks the chemical bonds in the amorphous 
phase. Backbone is continuously fragmented 
into smaller chains until those oligomers are 
soluble in aqueous media and then eliminated 
by the excretory system. This causes an initial 
reduction in the molecular weight without a loss 
of physical integrity of the device due to the fact 
that the device matrix is held together by the 
crystalline regions. Afterwards, water further 
fragments the implant and loss of physical 
properties follows. The water penetration into 
the crystalline phase is very limited, and so is 
the hydrolytic degradation at crystalline regions. 
The result is large amounts of independent 
small and rough, highly crystalline and resistant 
remnants. Such particles are known to be highly 
inflammatory and may cause post implantation 
responses (Bergsma et al., 1995).
Bergsma et al. (1995) conducted a study on 
patients with zygomatic fractures that received 
PLLA plates and screws for up to 5.7 years, even 
after which there were highly crystalline PLLA 
particles internalized by various cells and also 
remnants of degraded PLLA material surrounded 
by a dense fibrous capsule. Although those 
particles do not cause irritation or injury to cells, 
there were swellings at the implantation sites 
in some of the patients. These give some ideas 
about the fate of those materials within the body, 
though, it is to be reminded that in practice, host 
reaction depends on different factors including 
implant size and shape and implantation site. 
Additionally, by producing PLA with different 
ratios of chiral lactides or their copolymers with 
glycolide, crystallinity, degradation rates and 
mechanical properties of the polymers can be 
adjusted to particular needs of the implants. 
3.3. Biodegradable Bone Plates  
and Screws for Oral  
and Maxillofacial Surgery
Lactosorb® (Biomet Microfixation Inc, 
USA) is a PLLA/PGA (82:18) copolymer based 
craniomaxillofacial fixation system that is 
composed of plates of different geometries and 
screws, both of which are absorbable. According 
to the product catalog of the manufacturer, 
this system has been used in more than 50,000 
craniomaxillofacial surgeries since the first 
release at 1996. A 2004 study reviewed results 
of 1883 pediatric craniofacial surgeries in which 
resorbable plate and screw fixation systems were 
used (Eppley et al., 2004). Operations by 12 
surgeons who used Lactosorb® as the fixation 
system for a 5-year period were evaluated. The 
complications resulting from these actions 
were: infection (0.2 %), device instability due to 
postoperative trauma (0.3 %), and self-limiting 
local foreign body reactions (0.7 %). The overall 
reoperation rate due to device-related problems 
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was 0.3 % of the cases, which is less frequent than 
observed with metallic bone fixation systems. 
Authors stated that resorbable bone fixation for 
the rapidly growing cranial vault of infants has 
fewer potential complications than traditional 
metal plate and screw fixation systems. 
A cranial/maxillary bone union healing 
requires approximately 8 weeks and after this 
duration Lactosorb plates were claimed by 
the manufacturer to retain 70 % of their initial 
strength, making them appropriate for use in 
fractures of this area (Lactosorb brochure). Screws 
of this system show a 90 % strength loss profile of 
12 weeks, which is claimed to be compatible with 
the duration of normal healing process (Mitchell 
et al., 2005). Pietrzak et al. (2009) suggested a 
material with almost the same composition (85:15 
lactide to glycolide molar ratio), higher inherent 
viscosity and smaller polydispersity to be used in 
patients where a delayed healing is foreseen. This 
new material had the same initial tensile modulus 
of 0.8 GPa as the 82:18 PLGA, but the strength 
retention was longer (up to 44 weeks). 
3.4. Biodegradable Interface Screws
In anterior cruciate ligament (ACL) 
reconstruction surgeries, one end of the ligament 
is fixed to the lower femoral head while the other 
to the upper tibial head, with one screw at each 
site. Along with the classical metal screws, there 
are now commercially available biodegradable 
screws especially popular in knee surgeries. 
Konan and Haddad (2009) wrote an extensive 
clinical review about the currently available 
commercial biodegradable screws for ACL 
reconstruction surgeries.
According to a randomized clinical trial on 
85 patients having arthroscopic patellar tendon 
autografts (Barber et al., 1995), commercial 
PLLA interference screws showed essentially 
no difference in terms of ease of application or 
patient’s healing period when compared to metal 
screws used in the same application. In a similar 
study, PLLA and titanium interference screws led 
to comparable results in 97 patients having bone 
patellar tendon autograft reconstruction of ACL 
(Keading et al., 2005).
PLLA has a crystallinity of about 37 % and, 
thus, it is one of the most sturdy biodegradable 
polymers, making it suitable as bone implants. 
However, this is accompanied by a lowered 
degradation rate within the body. A study by 
Ma et al. (2004) showed that after interference 
screw fixation of hamstring autograft ACL 
reconstruction on two groups of 15 patients with 
24 to 40 months follow-up, 83 % of all implanted 
PLLA screws were found to be intact or only 
partially degraded. This situation increases the 
risk of late stage inflammatory reactions. 
There are some other commercially 
produced biodegradable screws including the 
ones made from poly (D,L-lactide) (PDLLA), 
poly (D,L-lactide co-glycolide) (PLDLGA), and 
the composite poly (L-lactide) – β-tricalcium 
phosphate. They do their job fairly well, but one 
thing that is in common with all these examples is 
the lack of follow-up studies in terms of number 
of patients compared to the classical metal 
screws in use for a much longer duration (Konan 
and Haddad, 2009). Although their mechanical 
properties can match the healing profile of the 
tissue, the most important suspects about their 
use is the potential biologically adverse responses 
by the host and this is especially difficult to assess 
with in vivo studies due to the fact that such 
reactions are species specific.
4. Bioerodible Ceramic Hard  
Tissue Implants
Bone grafts are needed in orthopedic 
surgeries in cases with a bony defect and 
autologous bone, taken usually from the iliac 
crest, is still the gold standard in this respect. 
However, donor site morbidity and sometimes 
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scarcity, the risk of infection, the pain and need of 
the secondary operation are the main factors that 
render this option not ideal. Use of allografts or 
xenografts are other options, however, this runs 
the risk of disease transmission and excessive 
host immune responses. 
The logical option would be the use of a 
material that is free from risks associated with 
human- or animal-origin grafts, available in 
sufficient quantities, and produced with desired 
properties that would assist integration to bone 
and induce osteogenesis. Therefore, a large 
number of different bone graft materials have 
been produced until now from a variety of 
materials such as bioactive or inert ceramics, 
polymers, metals, and materials obtained from 
natural sources like corals. 
Calcium phosphate derivatives are the 
most commonly used ceramic materials in bone 
regeneration studies, which are due to the fact 
that mineral constituent of bone is a calcium 
phosphate that is in the form of carbonate 
apatite. Current medical applications of calcium 
phosphate biomaterials consist of repair or 
augmentation of periodontal defects and alveolar 
bone, sinus lifts and tooth replacements, filling 
of large bone defects after tumor removal, spine 
fusions, and ear and eye implants (LeGeros, 
2008). They are also used as scaffolds in tissue 
engineering of bone and dentin, as injectable 
bone cements, or as coatings on some metallic 
bone implants. Those ceramics have proven 
positive effects on bone regeneration due to 
their being osteoconductive, bioactive, and even 
bioresorbable. Interconnecting porosity can be 
achieved in such materials by use of porogens 
or by other means to promote cell attachment, 
proliferation, and differentiation and to serve as 
paths for fluid drainage. This is also crucial in 
bone tissue engineering applications; however, 
the inherent high brittleness of ceramics makes 
the porous forms of those materials very low 
in strength and in toughness, thus severely 
suppressing their clinical use (Yaszemski et al., 
1996). 
Production of different phases with different 
resulting properties of calcium phosphates is 
possible. The molar ratio of calcium to phosphate 
(Ca/P) can be in the range 1.5 to 2.0. β-tricalcium 
phosphate (β-TCP) (Ca/P: 1.5) and HAP (Ca/P: 
1.66) are the mostly evaluated calcium phosphate 
ceramics. β-TCP is the most readily bioerodable 
member of the group whereas HAP is chemically 
very similar to the mineral constituent of bone. 
Grafts produced from a combination of these two 
forms are called biphasic calcium phosphates and 
are more effective in bone regeneration than the 
pure forms of either phase (Ramay and Zhang, 
2004). This combination gives the implant the 
advantage of adjustable erosion rate.
Brittleness and low-fatigue resistance 
of calcium phosphate materials are the most 
important shortcomings that restrict their use in 
load-bearing applications. Fracture toughness is 
the ability of a material to resist fracture when 
containing a crack within the materials matrix, 
and it is an important property to be considered 
for virtually any engineering design. Fracture 
toughness of HAP is lower than 1 MPa m½, which 
is much lower than that human bone, which is 2 
to 10 MPa m½. Furthermore, this value decreases 
linearly with increasing porosity (Suchanek, 
1998). These indicate that a pure HAP implant 
would undergo a rapid failure above a certain 
stress, unlike the bone which shows a ductile 
fracture behavior. Thus, medical applications of 
ceramic materials are virtually limited mostly to 
filling large defects in bones.
Despite the mechanical disadvantages of 
calcium phosphates, there are certain areas of 
application where their high level of chemical 
and cellular bone compatibility can be used to an 
advantage. Since these materials are essentially 
bioerodible and their chemical compositions 
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are very similar to those of bone, they can be 
easily used for void filling where cellular bone 
remodeling process uses them to regenerate 
the defect area. For example, self-setting bone 
cements containing calcium phosphate can be 
injected and allowed to set in the defect site after 
completely filling the gap and taking the form of 
the defect (Bohner, 2000). Furthermore, there 
are some forms of them in which a certain level 
of porosity can be obtained after setting in the 
defect zone to allow tissue ingrowth. 
5. Biodegradable Metal Hard  
Tissue Implants
Use of metals as hard tissue implants is 
as ancient as the history of biomaterials due to 
the high compressive and tensile strength and 
modulus of metals. Through time, a large number 
of alloys were discovered, especially to increase 
their biocompatibility. The most important 
disadvantage of these materials is their long term 
presence in the body, which eventually ends 
with a complication necessitating their removal. 
Recent studies in the field are about the change 
their fate especially shortening their presence by 
use of degradable implants.
Biodegradable metals are especially made of 
magnesium alloys in which the material surface 
exchanges ions with the surrounding physiological 
medium. Dissolution occurs as a result of oxidation 
reactions and the ions that leave the metal react 
with water to form unreactive metal hydroxides 
or oxides. Magnesium is a naturally occurring 
metallic element and has important physiological 
functions in homeostasis like acting as a cofactor 
for many enzymes and also increasing the stability 
of DNA and RNA (Hartwig, 2001). Therefore, an 
efficient magnesium excretion system is present 
in the body and magnesium accumulation to 
toxic levels is not expected (Vormann, 2003). 
This is actually a prerequisite for considering the 
use of magnesium based biodegradable implants, 
because compared to other polymeric or ceramic 
materials, the degradation rate of magnesium 
based implants in the physiological environment 
is very rapid and the degradation products have 
to be rapidly eliminated in order to not cause 
problems. 
Modulus of elasticity for magnesium implants 
is between 41-45 GPa, a value much lower than 
any of the currently available metallic implants 
(Staiger et al., 2006) but it is closer to modulus of 
elasticity of natural bone (10-30 GPa, Nagels et al., 
2003), and, therefore a highly desirable property 
of hard tissue implants because this reduces stress 
shielding. Pure magnesium materials also have a 
low but appropriate compressive strength value 
of 100 MPa (100-130 MPa for bone). 
5.1. Biocompatibility of Magnesium Ions
Magnesium is suggested to have a 
biochemical role in bone formation. Magnesium 
ion can form complexes with nucleic acids due to 
the negatively charged sugar-phosphate backbone 
of the latter, and electrostatically stabilizes base 
pairing and base stacking. Magnesium is not 
known whether it acts as gene regulator, however, 
it affects cell cycle in different ways (Wolf and 
Cittadini, 2003). 
Pure magnesium in vivo degrades very 
rapidly, and this form cannot be used as a hard 
tissue implant. A very early attempt to use a pure 
magnesium bone plate failed in as early as 8 days 
due to heavy corrosion (Lambotte, 1932). A screw 
made from a simple magnesium-aluminum-
manganese alloy was reported to be absorbed 
completely in 120 days after implantation 
(McBride, 1938); obviously the mechanical 
properties became unsuitable much earlier. 
Although service life of such simple magnesium 
alloy implants are far shorter than complete 
healing of a bone fracture, lack of any systemic 
reactions or local inflammatory response and 
positive effect on callus formation at fracture site 
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encouraged scientists to continue their research 
in developing longer-lasting magnesium alloys. 
A problem associated with the use of magnesium 
implants is the liberation of hydrogen gas in the 
chlorine rich tissue fluids, which occurs at such 
a high rate that the body cannot eliminate it. 
This leads to formation of gas cysts around the 
implant site, and in the worst case even cause gas 
gangrene (McCord, 1942). Magnesium alloys 
were abandoned, mainly due to this problem, 
after the stainless steel became available in the 
1950’s (Witte et al., 2005).
A recent article by Zberg et al. (2009) 
addresses this issue where they present a new 
glassy magnesium alloy containing calcium 
and zinc which is said not to cause hydrogen 
gas formation, in vivo. This is reported to be 
due to the formation of a zinc and oxygen rich 
passivating layer on the implant surface when the 
zinc content of the alloy is higher than a certain 
threshold value.
With the increased awareness of potential of 
biodegradable implants and discovery of advanced 
alloying techniques, research on the magnesium 
as an implant material is continuing. It was 
discovered that addition of rare earth elements 
also decreases the in vivo corrosion rate (Staiger 
et al., 2006). There have been many attempts to 
decrease the degradation rate of magnesium by 
evaluating different alloy combinations with 
zinc, calcium, yttrium, cadmium, manganese, 
and aluminum in order to obtain a mechanical 
integrity that would better match the healing 
profile of bone fractures (Gu et al., 2009; Hänzi 
et al., 2009). Witte et al. (2005) studied in vivo 
degradation of new generation magnesium alloys 
after they prepared magnesium alloys containing 
two different aluminum and zinc ratios (3:1 Al:Zn 
w/w, called AZ31, and 9:1 Al:Zn w/w, called 
AZ91). They also prepared two magnesium 
alloys containing either yttrium or lithium 
and aluminum; both containing two different 
compositions of a rare earth metal mixture that 
is composed of cerium, lanthanum, neodymium 
and praseodymium (called WE43 and LAE442, 
respectively). They prepared implant rods and 
used a biodegradable polymer; self reinforced 
PLA, as reference. Rods were implanted into the 
femur of guinea pigs for 18 weeks. The study 
showed that surface of the magnesium alloys 
were coated with newly formed bone mineral 
that was in direct contact with the surrounding 
bone tissue, where new bone formation was 
significantly higher, than with polymer samples. 
Degraded mass of all magnesium implants was 
replaced by a thick layer of calcium. Hydrogen 
gas accumulation was much lower than the cases 
reported previously in the literature, and when 
removed by a syringe, this stopped accumulating 
after the first week. Rare earth metals stayed in the 
implant and were not detected in the surrounding 
bone. The most corrosion resistant alloy was 
LAE442, while others showed similar corrosion 
rates. These results suggest that magnesium 
alloys can be biocompatible, osteoconductive, 
with controllable degradation properties and, 
thus, suitable for hard tissue implantation.
5.2. Mechanical Properties  
of Magnesium Alloys
There are other problems associated with 
magnesium alloys to be solved. One of them is the 
initial, right after implantation, strength reduction 
of magnesium alloys. Zhang et al. (2006) reported 
that with only 6 % loss of initial weight, bending 
strength of a magnesium-zinc alloy decreased 
from 625 MPa to 390 MPa, a decrease to almost 
60 %. A logical approach to increase the service 
life of magnesium alloy implants is to use an 
implant material with inherent strength higher 
than actually desired. Also, magnesium alloys 
usually have an inherent non-uniform surface 
corrosion pattern, causing pits on the surface 
(Witte et al., 2005, Gu X et al., 2009, Zhang S 
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et al., 2009). These tend to spread laterally and 
produce a higher implant surface area that is more 
prone to attack by ions of the surrounding tissue 
fluid, resulting in an even higher degradation 
rate. Moreover, those pits lead to particle losses 
and decrease the mechanical strength (Song and 
Atrens, 2003). 
Most of the magnesium alloys designated 
as biomaterial contain aluminum and/or rare 
earth elements. However, it is well documented 
that aluminum can harm osteoblasts (Ku et 
al., 2002) and neurons, and is also associated 
with Alzheimer’s disease (El-Rahman, 2003). 
Meanwhile, rare earth elements can cause 
hepatotoxicity in rats (Yumiko et al., 1997). 
Excess yttrium was demonstrated to cause 
changes in some gene expressions and have 
undesirable effects on DNA transcription factors 
in rats (Yang et al., 2006). Although these adverse 
effects of such elements in magnesium alloys 
were not shown in humans, some researchers are 
already trying to avoid using them by utilizing 
other molecules such as calcium, zinc, and 
manganese, that are known to be better tolerated 
by the body (Xu et al., 2007; Li et al., 2008). Zinc, 
for example, is an abundant nutritional element 
and is known to be generally well tolerated in 
the body (Tapiero and Tew, 2003). Moreover, it 
was found that addition of zinc to magnesium 
alloys can increase corrosion resistance and 
strengthen them (Zhang et al., 2009). The latter 
authors obtained a zinc containing (6 %, w/w) 
magnesium alloy with ca. 42.3 GPa modulus 
of elasticity, 279 MPa tensile strength, and 434 
MPa compressive strength; which showed that 
this biomaterial is mechanically compatible 
with bone. 
6. Conclusion
Advances in materials science and 
technology and a better understanding of the 
nature of bone help us design more compatible 
hard tissue implants, both biologically and 
mechanically. There are different classes of 
biodegradable materials already available, 
at least conceptually, that may serve these 
purposes. Biodegradable polymers constitute a 
group of materials with diverse properties. They 
may be flexible or rigid; they may be elastic or 
not, and they are resilient in general. They can 
be produced to have similar properties with 
some biological materials of different physical 
properties. Their production methodologies 
are flexible, so that they may be blended, 
copolymerized, or crosslinked in order to obtain 
different chemical and physical characteristics. 
Although they found a high number of application 
areas as biomaterials, this is not valid especially 
in bone implants due to their low mechanical 
properties. Except for some extremely 
crystalline types, they usually undergo plastic 
deformation under high stress levels that could 
result from normal activities of skeletal system. 
Therefore, blends of crystalline and amorphous 
polymers with optimized mechanical properties 
find use in a number of hard tissue implants. 
Use of crystalline polymers, however, raise 
immunogenicity issues due to their low rate 
of degradation. Biodegradable polymers have 
great potential as hard tissue implants but some 
problems still need to be resolved.
On the other hand, bioceramics, like the 
bone itself obtained from animals or cadavers, 
or from seashells were the first implant materials 
to serve this purpose due to their immediate 
availability. The problem with them, however, is 
that bone obtained from cadavers is brittle when 
dry or may be immunogenic or even toxic when 
wet. Synthetic or natural ceramic bone analogs 
or fixtures basically share the same mechanical 
properties with dry bone. Due to their chemical 
similarities to bone, however, calcium phosphate 
ceramics can increase the biocompatibility of 
other implant materials when used as coating on 
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them. Such uses constitute the most common way 
of utilizing them as bone biomaterials.
Biodegradable metals constitute the most 
recent class of materials in hard tissue implants 
that came after discovery of advanced alloying 
techniques. This enabled elongation of the very 
high degradability issues that is inherent with 
magnesium implants, which constitute the most 
prominent example of this class of materials. The 
inherent rapid hydrogen gas release problem of 
magnesium in physiological fluids was reported 
to be overcome in recent studies. Different 
compositions in magnesium alloys enabled 
production of implants that can mechanically 
better match to bone. The fast progress in the 
biodegradable metals indicates the high potential 
of these as bone implants. 
Production of biodegradable hard tissue 
implants is a challenging field of research where 
there is no one perfect material or production 
method yet that fits perfectly to the complex 
needs of bone healing process. Advances in 
engineering technologies and our understanding 
of bone biology will certainly enlighten our way 
to the ultimate bone implant. The new solutions 
can be found in the biomimetic composites like 
the original bone itself and benefit from what 
nano- and microtechnology started to offer such 
as nanoparticles, and patterned surfaces carrying 
bone inducing bioactive species.
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Биоразлагаемые имплантаты для твердых тканей
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Старение населения и уменьшение физических нагрузок вследствие повышения уровня 
жизни являются превалирующими и неизбежными факторами, ведущими к уменьшению 
костной массы, минеральной составляющей костной ткани, а также снижению мышечной 
силы у современного человека. В результате этого увеличивается частота переломов на 
протяжении жизни. Хотя костная ткань обладает способностью к регенерации, сравнимой 
с другими тканями организма, существуют специфические особенности для восстановления 
ее целостности – сопоставление и фиксация отломков костей на время, необходимое для 
заживления.  Разработаны различные технологии и средства, для придания заменителям 
костной ткани необходимых свойств. Большинство  доступных средств фиксации 
изготавливают из некорродирующих металлов по причине их твердости и прочности, т.е. 
свойствам, обеспечивающим скелетной системе способность нести механическую нагрузку. 
В идеале, фиксирующий имплант должен быть временным, с возможностью  удаления после 
восстановления нормальных функций, для предотвращения развития таких осложнений, как 
развитие имплантат-ассоциированных инфекций на поздних стадиях, резорбция кости или 
иммунные реакции. Операции по удалению фиксирующих имплантатов,  вживленных в  кость, 
нередко ведут к серьезным повреждениям новообразованной ткани костной мозоли. Другая, 
не менее важная проблема при фиксации металлическими средствами заключается в том, 
что металл обладает более высокими прочностными характеристиками по сравнению с 
костной тканью. Вследствие этого свойства металлических протезов механический стимул, 
являющийся необходимой физиологической составляющей для полноценности формирующейся 
кости, отсутствует. Исходя из необходимости решения данных проблем, предлагается 
использовать различные биодеградируемые и биоразлагаемые материалы для изготовления 
фиксирующих устройств при переломах кости. В статье дан обзор развития и трендов в 
области биодеградируемых имплантатов для твердых тканей, применяющихся материалов и 
их совместимости с костной тканью.
Ключевые слова: имплантаты для твердых тканей, биодеградируемые полимеры, 
биоразлагаемая керамика, биодеградируемые металлы, биомеханика, биосовместимость.
